|
|
||||||||||
|
Implied VHT Analyst Target Price: $299 The Online Investor Staff - Mon., Apr. 29, 9:43 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $299.26 per unit. Read More » Repare Therapeutics Becomes Oversold (RPTX) The Online Investor Staff - Tue., Apr. 2, 12:17 PM Surprising Analyst 12-Month Target For VHT The Online Investor Staff - Thu., Mar. 28, 8:59 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $296.83 per unit. Read More » Repare Therapeutics (RPTX) Shares Cross Above 200 DMA The Online Investor Staff - Mon., Feb. 12, 4:57 PM Look Under The Hood: VHT Has 10% Upside The Online Investor Staff - Wed., Jan. 24, 6:58 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $282.99 per unit. Read More » Analysts Expect VHT Will Reach $280 The Online Investor Staff - Thu., Dec. 21, 7:16 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $280.27 per unit. Read More » Analysts Anticipate SPGM To Hit $58 The Online Investor Staff - Wed., Nov. 15, 7:11 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR Portfolio MSCI Global Stock Market ETF (SPGM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.11 per unit. Read More » Look Under The Hood: SPGM Has 16% Upside The Online Investor Staff - Mon., Oct. 16, 7:29 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR Portfolio MSCI Global Stock Market ETF (SPGM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.34 per unit. Read More » Repare Therapeutics Becomes Oversold (RPTX) The Online Investor Staff - Fri., Oct. 6, 11:46 AM RPTX Makes Bullish Cross Above Critical Moving Average The Online Investor Staff - Mon., Sep. 18, 5:00 PM Analysts Anticipate VHT Will Reach $291 The Online Investor Staff - Wed., Sep. 13, 6:41 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $290.74 per unit. Read More » Analysts Predict 38% Gains Ahead For The Holdings of IBBQ The Online Investor Staff - Tue., Aug. 8, 10:49 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $28.02 per unit. Read More » Oversold Conditions For Repare Therapeutics (RPTX) The Online Investor Staff - Thu., Jul. 27, 11:41 AM Implied VHT Analyst Target Price: $287 The Online Investor Staff - Thu., Jul. 6, 9:14 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $287.36 per unit. Read More » Sum Up The Parts: VHT Could Be Worth $286 The Online Investor Staff - Fri., Jun. 2, 7:12 AM Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Health Care ETF (VHT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $286.02 per unit. Read More »
|
|
||||||||||
Free Email Alerts:
Articles | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.